Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Ferrari · SciRah

Researcher profile · Semantic Scholar

D. Ferrari

Share profile

D. Ferrari — researcher profile on SciRah

h-index: 31
Works: 128
Citations: 3,349

Most-cited papers

Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
C. Cremolini, C. Antoniotti, D. Rossini, S. Lonardi +78 more
2020The Lancet Oncology239 citations Open access
Semantic Scholar
Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II–III trial
M. Ghi, A. Paccagnella, D. Ferrari, P. Foa +33 more
2017Annals of Oncology190 citations Open access
Semantic Scholar
Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13.
A. Luciani, G. Ascione, C. Bertuzzi, D. Marussi +7 more
2010Journal of Clinical Oncology188 citations
Semantic Scholar
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial.
M. Maltoni, E. Scarpi, M. Dall'Agata, V. Zagonel +50 more
2016European Journal of Cancer166 citations Open access
Semantic Scholar
Systematic versus on-demand early palliative care: A randomised clinical trial assessing quality of care and treatment aggressiveness near the end of life.
M. Maltoni, E. Scarpi, M. Dall'Agata, S. Schiavon +55 more
2016European Journal of Cancer157 citations Open access
Semantic Scholar
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.
V. De Sanctis, P. Bossi, G. Sanguineti, F. Trippa +10 more
2016Critical reviews in oncology/hematology154 citations
Semantic Scholar
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis.
T. Pressiani, C. Boni, L. Rimassa, R. Labianca +21 more
2013Annals of Oncology126 citations Open access
Semantic Scholar
Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy.
C. Pinto, C. Barone, G. Girolomoni, E. Russi +3 more
2011The Oncologist119 citations Open access
Semantic Scholar
A randomized, multicenter, phase II study of vandetanib monotherapy versus vandetanib in combination with gemcitabine versus gemcitabine plus placebo in subjects with advanced biliary tract cancer: the VanGogh study.
A. Santoro, V. Gebbia, T. Pressiani, A. Testa +14 more
2015Annals of Oncology106 citations Open access
Semantic Scholar
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study
A. Zaniboni, E. Aitini, S. Barni, D. Ferrari +7 more
2012Cancer Chemotherapy and Pharmacology81 citations Open access
Semantic Scholar
Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13).
A. Luciani, L. Biganzoli, G. Colloca, C. Falci +11 more
2015Journal of Geriatric Oncology75 citations
Semantic Scholar
Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer.
E. Bajetta, I. Floriani, M. Di Bartolomeo, R. Labianca +179 more
2014Annals of Oncology70 citations Open access
Semantic Scholar
Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review
A. Guidi, C. Codecà, D. Ferrari
2018Medical Oncology68 citations
Semantic Scholar
Concomitant chemoradiation (CRT) or cetuximab/RT (CET/RT) versus induction Docetaxel/ Cisplatin/5-Fluorouracil (TPF) followed by CRT or CET/RT in patients with Locally Advanced Squamous Cell Carcinoma of Head and Neck (LASCCHN). A randomized phase III factorial study (NCT01086826).
M. Ghi, A. Paccagnella, D. Ferrari, P. Foa +16 more
201467 citations
Semantic Scholar
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
P. Bossi, R. Miceli, L. Locati, D. Ferrari +16 more
2017Annals of Oncology65 citations Open access
Semantic Scholar
FOLFOX or CAPOX in Stage II to III Colon Cancer: Efficacy Results of the Italian Three or Six Colon Adjuvant Trial.
A. Sobrero, S. Lonardi, G. Rosati, M. Di Bartolomeo +17 more
2018Journal of Clinical Oncology64 citations
Semantic Scholar
Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a western population
D. Ferrari, C. Codecà, C. Bertuzzi, F. Broggio +7 more
2012BMC Cancer62 citations Open access
Semantic Scholar
Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II study.
S. Cascinu, R. Berardi, A. Sobrero, P. Bidoli +15 more
2014Digestive and Liver Disease51 citations
Semantic Scholar
Systematic vs. on-demand early palliative care in gastric cancer patients: a randomized clinical trial assessing patient and healthcare service outcomes
E. Scarpi, M. Dall'Agata, V. Zagonel, T. Gamucci +22 more
2018Supportive Care in Cancer50 citations Open access
Semantic Scholar
The value of lactate dehydrogenase serum levels as a prognostic and predictive factor for advanced pancreatic cancer patients receiving sorafenib
L. Faloppi, M. Bianconi, R. Giampieri, A. Sobrero +16 more
2015OncoTarget45 citations Open access
Semantic Scholar
The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality
D. Ferrari, M. Ghi, C. Franzese, C. Codecà +2 more
2020Frontiers in Oncology44 citations Open access
Semantic Scholar
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial.
S. Lonardi, A. Sobrero, G. Rosati, M. Di Bartolomeo +18 more
2016Annals of Oncology38 citations Open access
Semantic Scholar
Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer
C. Franzese, M. Badalamenti, A. Teriaca, A. De Virgilio +6 more
2021Journal of Cancer Research and Clinical Oncology37 citations Open access
Semantic Scholar
Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.
C. Vernieri, F. Galli, L. Ferrari, P. Marchetti +35 more
2019The Oncologist34 citations Open access
Semantic Scholar
Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial.
S. Lonardi, A. Sobrero, G. Rosati, M. Di Bartolomeo +18 more
2017Annals of Oncology32 citations Open access
Semantic Scholar
Management of Skin Reactions During Cetuximab Treatment in Association With Chemotherapy or Radiotherapy: Update of the Italian Expert Recommendations
C. Pinto, C. Barone, G. Girolomoni, E. Russi +3 more
2016American Journal of Clinical Oncology32 citations
Semantic Scholar
Screening elderly cancer patients for disabilities: evaluation of study of osteoporotic fractures (SOF) index and comprehensive geriatric assessment (CGA).
A. Luciani, L. Dottorini, N. Battisti, C. Bertuzzi +5 more
2013Annals of Oncology29 citations Open access
Semantic Scholar
Single agent panitumumab in KRAS wild-type metastatic colorectal cancer patients following cetuximab-based regimens
F. Pietrantonio, F. Perrone, P. Biondani, C. Maggi +14 more
2013Cancer Biology & Therapy29 citations Open access
Semantic Scholar
Multimodality treatment of osteosarcoma of the jaw: a single institution experience
D. Ferrari, C. Codecà, N. Battisti, F. Broggio +11 more
2014Medical Oncology28 citations
Semantic Scholar
Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: results of the first multicenter Italian study
R. Berardi, C. Mastroianni, Giuseppe Lo Russo, R. Buosi +34 more
2019Therapeutic Advances in Medical Oncology27 citations Open access
Semantic Scholar
Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in KRAS wild‐type metastatic colorectal cancer patients: the ObservEr Study
C. Pinto, F. di Fabio, G. Rosati, I. Lolli +18 more
2016Cancer Medicine26 citations Open access
Semantic Scholar
Efficacy and Safety of Anti-PD-1 Immunotherapy in Patients Aged ≥ 75 Years With Non-small-cell Lung Cancer (NSCLC): An Italian, Multicenter, Retrospective Study.
A. Luciani, A. Marra, L. Toschi, D. Cortinovis +18 more
2020Clinical Lung Cancer25 citations
Semantic Scholar
Long-term disease-free survival in surgically-resected oral tongue cancer: a 10-year retrospective study
A. Marra, M. Violati, F. Broggio, C. Codecà +9 more
2019Acta otorhinolaryngologica italica25 citations Open access
Semantic Scholar
A phase II-III study comparing concomitant chemoradiotherapy (CRT) versus cetuximab/RT (CET/RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Efficacy results (NCT01086826).
M. Ghi, A. Paccagnella, D. Ferrari, P. Foa +16 more
201325 citations
Semantic Scholar
Adjuvant role of anti-angiogenic drugs in the management of head and neck arteriovenous malformations.
G. Colletti, P. Dalmonte, L. Moneghini, D. Ferrari +1 more
2015Medical Hypotheses23 citations Open access
Semantic Scholar
Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma
F. Alongi, M. Bignardi, I. Garassino, S. Pentimalli +14 more
2011Strahlentherapie und Onkologie (Print)23 citations
Semantic Scholar
Performance of CT Colonography in Diagnosis of Synchronous Colonic Lesions in Patients With Occlusive Colorectal Cancer.
N. Flor, A. P. Ceretti, C. Luigiano, P. Brambillasca +3 more
2020AJR. American journal of roentgenology21 citations
Semantic Scholar
Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting.
R. Depenni, Maria Cossu Rocca, D. Ferrari, G. Azzarello +8 more
2019European Journal of Cancer19 citations
Semantic Scholar
Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA Phase 3 Randomized Trial.
F. Petrelli, E. Rulli, R. Labianca, S. Lonardi +17 more
2020Annals of Oncology18 citations Open access
Semantic Scholar
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial.
S. Cascinu, R. Berardi, R. Bianco, D. Bilancia +21 more
2021European Journal of Cancer17 citations
Semantic Scholar
Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysis.
T. Pressiani, C. Boni, L. Rimassa, R. Labianca +21 more
201317 citations Open access
Semantic Scholar
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial.
G. Rosati, S. Lonardi, F. Galli, M. Di Bartolomeo +23 more
2021European Journal of Cancer15 citations
Semantic Scholar
From CENTRAL to SENTRAL (SErum aNgiogenesis cenTRAL): Circulating Predictive Biomarkers to Anti-VEGFR Therapy
R. Giampieri, P. Ziranu, B. Daniele, A. Zizzi +20 more
2020Cancers15 citations Open access
Semantic Scholar
Disseminated cytomegalovirus disease after bendamustine: a case report and analysis of circulating B- and T-cell subsets
A. Cona, D. Tesoro, M. Chiamenti, E. Merlini +7 more
2019BMC Infectious Diseases14 citations Open access
Semantic Scholar
The impact of fatigue and anemia on functional status in older cancer patients treated with chemotherapy
A. Luciani, P. Jacobsen, M. Extermann, P. Foa +5 more
201213 citations
Semantic Scholar
Cetuximab/radiotherapy (CET+RT) versus concomitant chemoradiotherapy (cCHT+RT) with or without induction docetaxel/cisplatin/5-fluorouracil (TPF) in locally advanced head and neck squamous cell carcinoma (LASCCHN): Preliminary results on toxicity of a randomized, 2x2 factorial, phase II-III study (N
M. Ghi, A. Paccagnella, D. Ferrari, P. Foa +16 more
201213 citations
Semantic Scholar
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: final results of the GISCAD (Italian Group for the Study of Digestive Tract Cancers) CENTRAL (ColorEctalavastiNTRiAlLdh) trial
R. Giampieri, M. Puzzoni, B. Daniele, D. Ferrari +14 more
2017British Journal of Cancer12 citations Open access
Semantic Scholar
Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic Regions
P. Economopoulou, A. Pantazopoulos, A. Spathis, I. Kotsantis +19 more
2021Cells11 citations Open access
Semantic Scholar
A dose‐dense short‐term therapy for human immunodeficiency virus/acquired immunodeficiency syndrome patients with high‐risk Burkitt lymphoma or high‐grade B‐cell lymphoma: safety and efficacy results of the “CARMEN” phase II trial
A. Ferreri, C. Cattaneo, A. Lleshi, L. Verga +14 more
2020British Journal of Haematology9 citations Open access
Semantic Scholar
Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies
A. Rachiglio, L. Forgione, R. Pasquale, C. Barone +20 more
2022Cancers8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Zaniboni×14
Invite
A. Zaniboni — researcher profile on SciRah
R. Labianca×14
Invite
R. Labianca — researcher profile on SciRah
P. Foa×13
Invite
P. Foa — researcher profile on SciRah
C. Codecà×13
Invite
C. Codecà — researcher profile on SciRah

×11

Invite

V. Zagonel — researcher profile on SciRah

Invite

E. Maiello — researcher profile on SciRah

Invite

M. Banzi — researcher profile on SciRah

Invite

G. Rosati — researcher profile on SciRah

Invite

S. Lonardi — researcher profile on SciRah

Invite

A. Luciani — researcher profile on SciRah

Invite

S. Barni — researcher profile on SciRah

L. Ciuffreda×8

Invite

L. Ciuffreda — researcher profile on SciRah